Ligand Pharmaceuticals Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	47,963	40,675	32,234	-1,655	15,020	1,079
Depreciation & Amortization	21,721	18,545	16,024	16,907	18,642	21,633
Other Amortization	39.65	-	-	-	161.19	69.17
Other Operating Activities	-90,726	-151,270	-13,855	14,672	-57,640	-6,593
Operating Cash Flow	-21,003	-92,050	34,404	29,924	-23,816	16,189
Operating Cash Flow Growth	-	-	14.97%	-	-	-
Capital Expenditures	-1,427	-34,052	-67,534	-8,769	-1,343	-2,245
Sale of Property, Plant & Equipment	2,056	272	18,514	1,349	1,095	2,387
Sale (Purchase) of Intangibles	-153.03	-153.03	-	-	-558.88	-
Investment in Securities	-	-	-	16,250	-	-
Other Investing Activities	-14,500	-14,500	2,000	-2,000	32,615	-
Investing Cash Flow	-14,024	-48,433	-47,020	6,830	31,808	141.84
Short-Term Debt Issued	-	636,159	134,044	348,740	275,972	205,376
Long-Term Debt Issued	-	5,580	46,760	-	2,207	-
Total Debt Issued	599,369	641,739	180,804	348,740	278,179	205,376
Short-Term Debt Repaid	-	-532,916	-162,983	-335,899	-267,460	-212,372
Long-Term Debt Repaid	-	-13,747	-7,309	-31,583	-17,834	-10,752
Total Debt Repaid	-584,540	-546,664	-170,292	-367,483	-285,295	-223,125
Net Debt Issued (Repaid)	14,830	95,076	10,512	-18,743	-7,115	-17,749
Issuance of Common Stock	-	74,750	-	-	-	-
Common Dividends Paid	-9,744	-	-	-5,500	-	-
Other Financing Activities	406.92	-2,221	-	-	-	-
Financing Cash Flow	5,493	167,605	10,512	-24,243	-7,115	-17,749
Foreign Exchange Rate Adjustments	103.14	103.14	0.32	2.45	0.3	0.16
Net Cash Flow	-29,430	27,226	-2,104	12,514	876.9	-1,418
Free Cash Flow	-22,430	-126,101	-33,131	21,155	-25,160	13,943
Free Cash Flow Margin	-5.39%	-35.40%	-14.27%	10.85%	-22.47%	9.05%
Free Cash Flow Per Share	-7.13	-40.10	-12.74	8.14	-27.95	15.49
Cash Interest Paid	17,785	14,309	7,177	6,959	9,266	9,925
Cash Income Tax Paid	18,400	11,960	4,140	-16,655	2,896	6,092
Levered Free Cash Flow	-16,127	-146,720	-33,709	11,726	-19,047	-
Unlevered Free Cash Flow	-7,064	-138,210	-29,223	16,075	-13,563	-
Change in Net Working Capital	77,203	165,177	-1,372	3,165	35,182	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.